Advisor Group Holdings, Inc. Centessa Pharmaceuticals PLC Transaction History

Advisor Group Holdings, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$8.04 - $11.87 $860 - $1,270	107 Added 35.67%	407 $3,000
Q1 2024 May 10, 2024	SELL	$6.73 - $12.2 $11,427 - $20,715	-1,698 Reduced 84.98%	300 $3,000
Q4 2023 Feb 12, 2024	SELL	$5.52 - $8.03 $4,498 - $6,544	-815 Reduced 28.97%	1,998 $15,000
Q3 2023 Nov 13, 2023	SELL	$6.01 - $8.24 $2,181 - $2,991	-363 Reduced 11.43%	2,813 $18,000
Q2 2023 Aug 10, 2023	BUY	$3.68 - $6.9 $1,586 - $2,973	431 Added 15.7%	3,176 $19,000
Q4 2022 Feb 10, 2023	BUY	$3.05 - $4.19 $2,623 - $3,603	860 Added 45.62%	2,745 $8,000
Q3 2022 Nov 14, 2022	SELL	$3.8 - $5.91 $247 - $384	-65 Reduced 3.33%	1,885 $7,000
Q2 2022 Aug 10, 2022	BUY	$3.18 - $9.85 $2,973 - $9,209	935 Added 92.12%	1,950 $8,000
Q1 2022 May 04, 2022	BUY	$7.45 - $11.59 $7,561 - $11,763	1,015 New	1,015 $9,000

108

118M

5.9K

53K

Ticker CNTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,339,296
Market Cap $1.62B
Description
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.